Article metrics

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study

 

Online download statistics by month:

Online download statistics by month: September 2024 to November 2024

AbstractFullPdf
Sep 2024455432132
Oct 202419419254
Nov 2024999815
Total748722201